Sumitomo Pharma has entered a rebound phase following reports that it raised its earnings forecast for the fiscal year ending March 2027, with the stock surging in afternoon trading. It is up about 7% from the previous day, having reached an intraday high of ¥2,074.5, and is currently trading around ¥2,016.
Sumitomo Pharma is rebounding sharply following reports that it raised its earnings forecast for the fiscal year ending March 2027. During the 1 p.m. hour, the stock was up ¥131.5 from the previous day at ¥2,016.
The company is a mid-tier pharmaceutical company affiliated with Sumitomo Chemical, and the upward revision to its earnings forecast appears to have lifted its market valuation. The stock also rose as high as ¥2,074.5 at one point.